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Aims: We evaluated associations between history of syphilis infection and both 
cognitive function and depressive symptoms in people living with HIV (PLWH) and 
comparable HIV-negative controls. 
Methods: Syphilis serological tests, cognitive function and depression were assessed in 
PLWH and controls participating in the POPPY study. Cognitive test scores were 
converted to demographically-adjusted T-scores (mean=50, SD=10) and then averaged 
to obtain a global T-score. Severity of depressive symptoms was assessed via the 
Patient Health Questionnaire (PHQ-9). Associations of syphilis with global T-scores 
and depression were assessed using median regression. 
Results: The 623 PLWH and 246 HIV-negative controls were predominantly male 
(89.3% and 66.5%) with median age (interquartile range, IQR) of 57 (53-63) and 58 
(53-63) years, respectively. PLWH had lower global cognitive T-scores [median (IQR) 
48.7 (45.1, 52.1) vs. 50.5 (47.0, 53.9), p<0.001], more severe depressive symptoms 
[median (IQR) 4 (1, 10) vs. 1 (0, 3), p<0.001] and were more likely to report history of 
syphilis infection (22.0% vs. 8.1%) than controls. There was no significant association 
between history of syphilis and global cognitive function in either PLWH (p=0.69) or 





symptoms [median (IQR) 4 (1, 9) vs. 2 (0, 8), p=0.03], however, the association became 
non-significant (p=0.62) after adjusting for HIV-status and potential confounders.  
Conclusions: Despite the higher prevalence of syphilis infection in PLWH, there was no 
evidence of an association between history of syphilis infection and impaired cognitive 








In recent years syphilis has seen a resurgence with the incidence increasing after decades 
of decline (1). Untreated syphilis can cause serious neurological sequelae, including 
cognitive and psychiatric disorders (2), which may be more common in people living with 
HIV (PLWH) and may occur earlier in the course of the infection (3).  Syphilis may be 
associated with cognitive impairment in PLWH (4), possibly as a result of higher rates of 
both symptomatic and asymptomatic neurological involvement in PLWH compared to 
HIV-negative controls. Indeed asymptomatic neurological involvement, based on 
cerebrospinal fluid findings, has been reported in 22.5% vs. 10% of PLWH and HIV-
negative controls, respectively (5) as well as an increased use of single dose benzathine 
penicillin for the treatment of early syphilis, which may not be as effective as other 
therapies in clearing treponema from the central nervous system (6). However, the 
contribution, if any, of past syphilis to cognitive impairment and depressive symptoms 
reported in PLWH remains unclear as previous studies have not fully controlled for 
lifestyle factors that may confound any relationships with past syphilis, which may be a 
marker of risk-taking behaviour. Here, we sought to determine the relationships between 
past syphilis infection and both cognitive function and depressive symptoms in a cohort 
of PLWH representative of people attending for care in the UK, as well as in 
demographically comparable HIV-negative controls. Our hypothesis was that HIV-





infection of syphilis being associated with poorer cognitive function and more depressive 
symptoms in PLWH. 
 
Methods 
Study design and participants 
The Pharmacokinetic and Clinical Observations in People Over Fifty (POPPY) study 
recruited a cohort of PLWH aged over 50 years as well as control cohorts of younger 
PLWH aged under 50 years and demographically comparable HIV-negative people aged 
over 50 years from HIV clinics, sexual health clinics and targeted community groups as 
described previously (7). Inclusion criteria for the groups of PLWH were: documented 
presence of HIV infection, self-defined white or black-African ethnicity, likely route of 
HIV acquisition via sexual exposure (either by male to male exposure if white or by 
heterosexual exposure if white or black-African) and the ability to comprehend the study 
patient information leaflet. The two control groups were frequency matched on gender, 
ethnicity, sexual orientation and location (in or out of London) to the group of older 
PLWH (with the control group of HIV-negative people additionally frequency matched 
for age). The study was approved by the UK National Research Ethics Service (NRES; 





consent.  The present analyses used information from the baseline POPPY visit only and 
included only the two older cohorts. 
Definition of syphilis infection 
Results of Treponema pallidum particle agglutination test (TPPA), rapid plasma regain 
(RPR) test and self-reported history of syphilis were combined to defined past and 
possible current syphilis infection as detailed in Table 1. Serology was undertaken locally 
at each POPPY clinical site with the screening algorithms dependent on local practice. 
Briefly, a history of syphilis infection was defined as either a positive Treponema 
pallidum particle agglutination test (TPPA) or a positive rapid plasma regain (RPR) test 
confirmed by a self-reported history of syphilis. A negative TPPA and/or RPR and a 
negative TPPA with a positive RPR but without a self-reported history of syphilis were 
considered as indicative of no history of syphilis infection. 
Assessment of cognitive function and depressive symptoms 
Assessment of cognitive function was performed using the CogState™ (Melbourne, 
Australia) battery (8), a computerised battery that has been previously used in cohorts of 
PLWH (9, 10). The assessment covered six cognitive domains, as described previously 
(11) and summarised in supplementary material. Quality checks were applied to ensure 
that scores were generated from completed and fully-understood tasks for each subject. 





of 50 and standard deviation of 10) accounting for age, gender, ethnicity and level of 
education, using the HIV-negative control group as the reference population. A global T-
score was calculated by averaging individual domain T-scores with higher values 
indicating better cognitive function.  
Depressive symptoms were evaluated using the Patient Health Questionnaire-9 (PHQ-9), 
the recommended tool for the assessment of depression in PLWH (12), with scores 
ranging from 0 (no depression) to 27 (severe depression) (13).  
Statistical analysis 
Pairwise group comparisons of socio-demographic and self-reported lifestyle 
characteristics between older PLWH and similarly-aged HIV-negative controls and 
between those with a history of syphilis and those without, were assessed using Chi-
square and Wilcoxon rank-sum tests as appropriate. The independent effects of syphilis 
and HIV-status (also independent of potential confounders) on both outcomes were 
evaluated using median regression models to minimise the influence of large outliers. 
Socio-demographic and lifestyle factors were included as potential confounders if they 
were significantly associated with the outcome (cognitive scores or depressive symptoms) 
and with a history of syphilis infection. Factors considered included age, gender, 
ethnicity, level of education, sexuality, self-reported smoking, alcohol consumption and 





syphilis infection and HIV-status, to test whether the associations between syphilis and 
each outcome differed across PLWH and HIV-negative controls. All analyses were 
performed using SAS v9.4 with p-values <0.05 considered as statistically significant. 
Results 
Participant Characteristics 
The 625 PLWH (median (IQR) CD4+ T cell count of 613 (470, 792) cells/µL; 92.5% with 
HIV RNA <50 copies/mL) and 248 HIV-negative controls were comparable in terms of 
age and smoking status (Table 2). However, PLWH were more likely to be male, men 
who have sex with men (MSM) and to have reported recreational and injected drug use 
but less likely to be current consumers of alcohol compared to HIV-negative controls.  
PLWH had overall poorer cognitive scores and more severe depressive symptoms 
compared to HIV-negative controls (median [IQR]: 48.7 [45.1, 52.1] vs. 50.5 [47.0, 53.9] 
and 4 [1, 10] vs. 1 [0, 3] p’s<0.001, Table 2). A total of 137 (22.0%) PLWH and 20 (8.1%) 
HIV-negative controls had a history of syphilis infection, with a significantly higher 
prevalence among PLWH than HIV-negative individuals (p<0.001).  
Cognitive function 
The median [IQR] global T-score was 48.4 [44.9, 52.1] and 49.4 [45.7, 52.8] in those 





was no association with poorer performance in any of the six cognitive domains, 
including working memory (median [IQR]: 49.8 [45.0, 54.9] vs. 50.4 [45.6, 54.4], 
p=0.60), visual (49.7 [44.1, 53.4] vs. 49.6 [44.7, 54.4], p=0.42) and verbal learning (48.8 
[42.7, 55.1] vs. 49.0 [42.5, 55.1], p=0.65). The difference in the global T-score remained 
non-significant after adjusting for HIV-status (p=0.23, Figure 1A) and for other 
confounders (age and years of alcohol consumption) (adjusted difference (95% CI) was -
0.7 (-1.9, 0.4), p=0.22). Additionally, there was no suggestion that the association 
between cognitive scores and a history of syphilis infection was modified by HIV-status 
(interaction p=0.71). 
Depressive symptoms 
Participants with a history of syphilis reported a 2.0 (0.7, 3.3) points higher median PHQ-
9 score than participants without (p=0.03, Table 2). After adjusting for HIV-status, the 
difference (95% CI) remained but was smaller: 1.0 (0.2, 1.8), p=0.02. However, after 
adjustment for potential confounders (alcohol consumption, smoking, recreational and 
injected drug use) the magnitude of the difference (95% CI) was further reduced and was 
no longer statistically significant: 0.1 (-1.0, 1.0), p=0.62. There was no difference in 
depressive symptoms within both groups (p=0.68 and p=0.27 in PLWH and HIV-negative 
controls, respectively, Figure 1B), and no interaction between history of syphilis 






Despite the increased prevalence of syphilis infection in PLWH, we did not find an 
association between past or possible current infection and impaired cognitive function 
nor depressive symptoms after accounting for potential confounders. Moreover, we did 
not find that HIV-status modified the relationships between current history of syphilis 
and cognitive function or depressive symptoms.  
These data are important as, to our knowledge, this is the largest study of syphilis and 
cognitive function in PLWH. A previous study from the CHARTER cohort compared 
cognitive function in 82 PLWH with previous syphilis and 52 who had never been 
infected with syphilis (4). Those with prior syphilis did not have higher rates of depressive 
symptoms. However, past syphilis was associated with a higher global deficit score and 
a higher rate of impairment in the learning domain. This contrasts with our findings, but 
it should be noted that the association with impairment in learning was attenuated after 
accounting for methamphetamine use and was no longer statistically significant. The 
large sample size in our study, comprehensive assessment and recruitment of 
demographically comparable HIV-negative controls allowed adjustment for potential 
confounders that may have exaggerated differences in cognitive function previously 
observed (4) between those who did and did not have a history of syphilis infection. Other 





PLWH and controls, however, it is unlikely that these would act in the opposite direction 
of the confounders we considered. It should be noted that the definition of syphilis we 
used was fairly conservative, in that participants who were RPR positive but reported no 
prior history of syphilis were not considered to have syphilis, given our study population. 
However only 1 HIV-positive participant was RPR positive without reporting prior 
history of syphilis and it is therefore unlikely that this resulted in a substantial bias. 
Moreover, whilst worse cognitive function and depressive symptoms could have been 
observed in participants with current syphilis compared to those with past syphilis or no 
history of syphilis, the small number of participants who may have had current syphilis 
infection (a maximum of 27 PLWH and 3 HIV-negative participants if possible current 
syphilis is assumed in those with either a positive RPR and TPPA or a positive RPR 
confirmed by a self-reported history of syphilis when TPPA was not done) did not permit 
full investigations of these associations.  We do not have data on the full treatment 
histories of syphilis to confirm if these individuals truly had untreated early syphilis or 
prior treated syphilis with persistent non-treponemal titers (sero-fast RPR). Of note, a 
sensitivity analysis in which individuals with possible current syphilis were excluded, 
yielded results that were comparable to the main results presented here (data of the 
sensitivity analysis not shown). 
In addition, whilst almost all PLWH considered were on successful antiretroviral therapy 





UK and Ireland (14), those not optimally treated and hence potentially with worse 
cognitive function and higher rates of syphilis infection, may be less represented in our 
study. Similarly, our findings were obtained in individuals aged over 50 years, so results 
cannot be generalised to younger cohorts of PLWH. As described above, an important 
limitation is the lack of accurate syphilis staging and treatment history. However, even if 
individuals with neurological involvement from syphilis received syphilis therapy not 
considered optimal for neurosyphilis, we would expect this to have increased the effect 
size observed and increased the presence of any neurological sequalae. Whilst syphilis 
can contribute to several psychiatric disorders (15), we only focused on depressive 
symptoms as depression is the most common psychiatric disorder in PLWH (16). 
Furthermore, the cross-sectional nature of our analyses limits our ability to establish 
temporal associations – future longitudinal analyses of this cohort may provide further 
insight to impact of past syphilis infection on changes in cognitive function and new-
onset depressive symptoms.   
In summary, in this large cohort of PLWH and HIV-negative controls we did not find 
evidence that a history of syphilis was independently associated with impaired cognitive 
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history of syphilis 
N (%) of 
PLWH 





Positive Negative Yes 86 (13.8%) 11 (4.4%) Standard serology for treated syphilis 
Positive Not done* Yes 24 (3.8%) 6 (2.4%) Standard serology for treated syphilis 
Positive  Positive  Yes 16 (2.6%) 1 (0.4%) Sero-Fast RPR or early syphilis 
Negative  Positive  Yes 0 (0.0%) 0 (0.0%) 
Early syphilis and not evolved positive 
TPPA serology 
Not done* Positive  Yes 11 (1.8%) 2 (0.8%) Sero-Fast RPR or early syphilis 
No history of 
syphilis 
Negative Negative No 168 (26.9%) 99 (39.9%) Standard serology for no history of syphilis 
Negative Positive No 0 (0.0%) 0 (0.0%) False positive RPR 
Not done* Positive No 1 (0.2%) 0 (0.0%) False positive RPR 
Negative Not done* No 315 (50.4%) 128 (51.6%) Standard serology for no history of syphilis 
Not done* Negative No 4 (0.6%) 1 (0.4%) Standard serology for no history of syphilis 






Table 2: Demographic, lifestyle and HIV-related characteristics by HIV- and syphilis-status at enrolment 
n (%) or median (IQR) 











Gender   <0.001   <0.001 
Male 558 (89.3%) 165 (66.5%)  151 (96.2%) 572 (79.9%)  
Female 67 (10.7%) 83 (33.5%)  6 (3.8%) 144 (20.1%)  
Age [years] 57 (53, 63) 58 (53, 63) 0.07 58 (54, 64) 57 (53, 62) 0.03 
Ethnicity   0.02   0.14 
Black-African 73 (11.7%) 16 (6.5%)  11 (7.0%) 78 (10.9%)  
White 552 (88.3%) 232 (93.5%)  146 (93.0%) 638 (89.1%)  
Sexual orientation   <0.001   <0.001 
MSM/homosexual 503 (80.5%) 128 (51.6%)  146 (93.0%) 485 (67.7%)  
Heterosexual 122 (19.5%) 120 (48.4%)  11 (7.0%) 231 (32.3%)  
Alcohol consumption   0.01   0.12 
Never consumed 46 (7.3%) 12 (4.8%)  5 (3.2%) 53 (7.4%)  
Previously consuming only 81 (13.0%) 17 (6.9%)  131 (83.4%) 586 (81.8%)  
Currently consuming 498 (79.7%) 219 (88.3%)  21 (13.4%) 77 (10.8%)  
If current/previous consumption      
Years drinking 38 (33, 45) 41 (35, 46) 0.02 40 (35, 48) 39 (34, 45) 0.02 
units/week 8 (3, 20) 10 (3, 20) 0.42 7 (2, 21) 9 (3, 20) 0.42 
Smoking status   0.06   0.15 





Ex-smoker 239 (38.4%) 102 (41.3%)  61 (39.1%) 280 (39.2%)  
Current smoker 132 (21.2%) 35 (14.2%)  38 (24.4%) 129 (18.1%)  
Ever injected drugs 58 (9.3%) 4 (1.6%) <0.001 23 (14.7%) 39 (5.5%) <0.001 
Recreational drugs 163 (26.1%) 38 (15.3%) <0.001 48 (30.6%) 153 (21.4%) 0.01 
Duration of HIV [years] 15.9 (10.1, 22.5) N/A  16.5 (11.7, 23.5) 15.8 (9.5, 22.3) 0.08 
CD4+ T cell count [cells/mm3] 613 (470, 792) N/A  601 (496, 712) 620 (463, 810) 0.49 
Nadir CD4+ count [cells/mm3] 180 (86, 270) N/A  189 (100, 261) 180 (84, 272) 0.55 
On antiretroviral therapy 617 (98.7%) N/A  136 (99.3%) 481 (98.6%) 0.52 
HIV RNA <50 copies/ml 576 (92.5%) N/A  128 (93.4%) 448 (92.2%) 0.62 
Global cognitive T-score 48.7 (45.1, 52.1) 50.5 (47.0, 53.9) <0.001 48.4 (44.9, 52.1) 49.4 (45.7, 52.8) 0.09 
PHQ-9 score 4 (1, 10) 1 (0, 3) <0.001 4 (1, 9) 2 (0, 8) 0.03 
Note: comparisons of duration of HIV, CD4+ T cell count, nadir CD4+ count, proportion on antiretroviral therapy and with HIV RNA <50 copies/ml between 







Figure 1: Global cognitive T-scores (A) and severity of depressive symptoms (B) in those with and without 








Supplementary table 1: Description of the cognitive tests administered 
Cognitive domain Tests Description of the score 
Visual Learning Continuous paired associate learning test Total number of errors across the 
seven rounds 
Groton Maze Learning test – delayed recall Total number of errors made after  
a delay 
One card learning task Arcsine of the square root of the 
proportion of correct responses 
Psychomotor function  Detection task Mean of the log10 transformed 
reaction times for correct responses 
Visual Attention  Identification task Mean of the log10 transformed 
reaction times for correct responses 
Executive Function  Groton Maze Learning test Total number of errors made in 
five consecutive trials 
Set shifting task Total number of errors across the five 
rounds 
Verbal Learning International Shopping list Total number of correct responses 
made in three consecutive trials 
International Shopping list – delayed recall Total number of correct responses 
made after a delay 
Working Memory and 
Attention 
One back task Mean of the log10 transformed 
reaction times for correct responses 
Arcsine of the square root of the 
proportion of correct responses 
Two back task Mean of the log10 transformed 
reaction times for correct responses 
Arcsine of the square root of the 
proportion of correct responses 
 
